Oct 29, 2019
Good employee health and wellbeing is of key importance to employers and to the economy. Yet, many businesses find it hard to invest in the health and wellbeing of their employees or do not invest at all. These problems are especially true for small and medium-sized enterprises (SMEs). There has been considerable interest in the effect of financial incentives to stimulate change in the workplace environment, but evidence is limited. The West Midlands Combined Authority (WMCA) is running a randomised controlled trial of a financial incentive programme to improve employee health and wellbeing in SMEs in the Wider West Midlands Region. RAND Europe and the University of Warwick have been commissioned by the WMCA to conduct an evaluation of this programme, the Wellbeing Premium Programme. The primary aim of the study is to establish whether SMEs will improve their health and wellbeing offer and achieve higher employee awareness and participation in wellbeing activities in response to a financial incentive offer.
This study, carried out by RAND Europe, focuses on better understanding the reasons behind companies' decisions to participate in the programme, including barriers, motivators and enablers that influence the success or otherwise of recruitment to the randomised trial. The remaining elements of the trial — an impact evaluation and a process evaluation — will measure the efficacy of the programme and explain how it was implemented and will try to achieve an understanding of potential behavioural change in the participating SMEs. The results of these evaluations are expected in 2020.
Recruitment strategy and approach
Drivers of and barriers to recruitment
Conclusions and lessons learned
Overview of SMEs consulted in the recruitment evaluation
Roles and responsibilities in the Thrive at Work trial